PRESENTATION: Syrup 120 ml
DESCRIPTION: Each 5 ml syrup contains: Diastase (1:50) 135 mg, pepsin 50 mg, papain BPC 50 mg, vitamin B1 5 mg, vitamin B2 2 mg, vitamin B6 2 mg, vitamin B12 5 mcg, calcium pantothenate 1 mg and nicotinamide 20 mg.
Enrich is a pleasantly flavored syrup, containing digestive enzymes and vitamins of the B-complex group. Abdominal cramps, flatulence, heartburn and nausea can occur as a result of indigestion. Enrich is the ideal cure to facilitate digestion and to strengthen the GlT.
Enrich’s balanced formulation provides an ideal supplementation that meets the demands and
replenishes vitamins stores in the body.
INDICATIONS: lndigestion, acidity, fermentation, loss of appetite, loss of taste, dyspepsia, heartburn.
PRESENTATION: Tab 10 mg >< 10's. 70 mg >< 4's.
DESCRIPTION: Each tablet contains alendronate sodium equivalent to 10 mg or 70 mg alendronic acid.
ACTIONS: Therapeutic Class: Bisphosphonates are synthetic analogs of pyrophosphate that bind to the hydroxyapatite found in bone Alendronate sodium is a bisphosphonate that acts as a potent, specific inhibitor of osteoclast-mediated bone resorption.
INDICATIONS: Drate 10 and 70 mg: Treatment and prevention of osteoporosis in postmenopausal women. Treatment to increase bone mass in men with osteoporosis. Drate 10 mg: Treatment of glucocorticoid-induced osteoporosis in men and women receiving gluco- corticoids, Treatment of Pagers disease of bone in men and women.
DOSAGE & ADMINISTRATION: 10-mg Tablet; Treatment and Prevention of Osteoporosis in Postmenopausal Women,
PRESENTATION: Film-Coated tab 100 mg x 1 x 10's. Oral Susp 40 mg/5 mL x 50 ml.
ACTIONS: Cefpodoxime proxetil is an orally administered, extended spectrum, semisynthetic antibiotic of the cephalosporin class. Cefpodoxime proxetil is a prodrug; its active metabolite is cefpodoxime.
Microbiology: Cefpodoxime is active in vitro against a wide range of gram-positive and gram-negative bacteria. Cefpodoxime is highly stable in the presence of ß-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins, due to the presence of p-lactamases, may be susceptible to cefpodoxime. The bactericidal activity of cefpodoxime results from its inhibition of cell wall synthesis. Cefpodoxime is usually active against the following organisms in vitro and in clinical infections: Gram-positive Aerobes: Staphylococcus aureus (including penicillinase-producing strains), Staphylococcus saprophyticus. Streptococcus pyogenes, Streptococcus pneumonia (excluding penicillin-resistant strains).
PRESENTATION: Tab 135 mg x 4O's.
ACTIONS: Mevrin 135 has a strong spasmolytic activity of the musculotropic type with a potent and selective action on the Gl spasms especially those of colon.
INDICATIONS: Functional Spasms of Colon: lrritable colon syndrome. primary form. lrritable colon after organic affections of GIT e.g., diverticulosis and diverticulitis of colon, regional enterocolitis, disorders of the gallbladder, biliary duct disturbances (biliary dyskinesia), duodenal ulcer and round ulcer, dysentery (especially that of anamnesis) and specific and nonspecific inflammation of the GlT.
DOSAGE & ADMINISTRAT|ON: 1 tab (135 mg) 3 times daily, preferably 20 min before meals. When the desired effect is reached, the dosage can be reduced progressively after a few weeks.
Page 1 of 3